1-20 of 605
Sort by
News

Understanding the Prognostic Impact of TP53 Mutations in Chronic Lymphocytic Leukemia

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Understanding the Prognostic Impact of TP53 Mutations in Chronic Lymphocytic Leukemia
News

Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma
News

ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia
News

Phase II CAPTIVATE Study: The 5.5-Year Update

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Phase II CAPTIVATE Study: The 5.5-Year Update
News

Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results
News

Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Venetoclax May Increase Toxicity But Not Efficacy When Added to R-CHOP in Double-Expressor DLBCL
News

Study Identifies Characteristics Related to Bispecific Antibody Response, Resistance

Leah Lawrence
Published: 2024
Abstract
Mid-July 2024
View News titled, Study Identifies Characteristics Related to Bispecific Antibody Response, Resistance
News

Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia
News

Patients With Functional High-Risk Multiple Myeloma Show High Response With Ide-Cel

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Patients With Functional High-Risk Multiple Myeloma Show High Response With Ide-Cel
News

Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Adenine Base Editors Could Offer Alternative Approach in Beta Hemoglobinopathies Gene Therapies
News

Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, Quad Regimen Reduces Risk of Progression, Death in Older Patients with NDMM
News

Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Survival Benefit Remains Unclear for Upfront AlloHCT in Untreated Aggressive ATL
News

Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Fewer Patients With CLL/SLL Switch From Zanubrutinib to Another BTKi
News

Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM
News

Rituximab Maintenance in MCL Found Advantageous After Firstline Treatment With Bendamustine-Rituximab

Thomas R. Collins
Published: 2024
Abstract
Mid-July 2024
View News titled, Rituximab Maintenance in MCL Found Advantageous After Firstline Treatment With Bendamustine-Rituximab
News

Phase I Study Shows Long-Term Efficacy of GPRC5D-Directed CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

Katie Robinson
Published: 2024
Abstract
Mid-July 2024
View News titled, Phase I Study Shows Long-Term Efficacy of GPRC5D-Directed CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
News

CARTITUDE-2 Cohort D: Cilta-Cel ± Len Effective for Multiple Myeloma

Lara C. Pullen, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, CARTITUDE-2 Cohort D: Cilta-Cel ± Len Effective for Multiple Myeloma
News

Bispecific Antibodies Potent Bridging Therapy to CAR T-Cell Therapy for R/R MM

Leah Lawrence
Published: 2024
Abstract
Mid-July 2024
View News titled, Bispecific Antibodies Potent Bridging Therapy to CAR T-Cell Therapy for R/R MM
News

Machine Learning Outperforms Full Blood Count in Iron Deficiency Screening

Thomas R. Collins
Published: 2024
Abstract
Mid-July 2024
View News titled, Machine Learning Outperforms Full Blood Count in Iron Deficiency Screening
News

Patients With Low-Grade NHL Experience High Rates of Mental Health Conditions

Ruth Jessen Hickman, MD
Published: 2024
Abstract
Mid-July 2024
View News titled, Patients With Low-Grade NHL Experience High Rates of Mental Health Conditions